Literature DB >> 24610613

Possible role of selective serotonin reuptake inhibitor sertraline on oxidative stress responses.

D Battal1, S Yalin, E D Eker, A Aktas, N O Sahin, M Cebo, M Berköz.   

Abstract

The naphthylamine derivative sertraline is a potent and selective inhibitor of serotonin reuptake into presynaptic terminals and the most widely used that has been shown to have both antidepressant and antianxiety effects. In the present study the possible role of sertraline (acute and chronically doses) was evaluated on lipid peroxidation levels and antioxidant enzyme activities in plasma and brain tissues of (10, 40, 80 mg/kg) sertraline treated Wistar albino rats (n=48). Lipid peroxidation levels (MDA) of plasma and brain tissue increased in all acute and chronic sertraline treated rats (p < 0.05). According to results of present study superoxide dismutase (SOD) levels of brain tissue decreased while plasma levels increased (p < 0.05) as compared with vehicle group. Catalase (CAT) levels of plasma and brain tissue and paraoxonase (PON) levels of plasma decreased (p < 0.05) as compared with vehicle group. Based on the data, it can be concluded that high dose sertraline administration enhances oxidative stress. Therefore, dose adjustment in depression patients seems significant as it may help prevention of further prognosis of the diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24610613

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

Review 1.  The role of oxidative stress in anxiety disorder: cause or consequence?

Authors:  Alessandra das Graças Fedoce; Frederico Ferreira; Robert G Bota; Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Res       Date:  2018-06-04

2.  In vitro cytogenotoxic evaluation of sertraline.

Authors:  Erman Salih Istifli; Rima Çelik; Mehmet Tahir Hüsunet; Nesrin Çetinel; Osman Demirhan; Hasan Basri Ila
Journal:  Interdiscip Toxicol       Date:  2019-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.